BPCE
MRNA icon

Bank Pictet & Cie (Europe)’s Moderna MRNA Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$977K Sell
13,947
-154,659
-92% -$8M 0.02% 142
2026
Q1 		$8.57M Sell
168,606
-156,059
-48% -$7.28M 0.18% 78
2025
Q4 		$9.57M Hold
324,665
– – 0.19% 74
2025
Q3 		$8.39M Sell
324,665
-409,021
-56% -$11.4M 0.17% 75
2025
Q2 		$20.2M Buy
733,686
+204,000
+39% +$5.37M 0.43% 53
2025
Q1 		$15M Hold
529,686
– – 0.36% 57
2024
Q4 		$22M Hold
529,686
– – 0.48% 51
2024
Q3 		$35.4M Buy
529,686
+7,060
+1% +$648K 0.84% 36
2024
Q2 		$62.1M Sell
522,626
-1,000
-0.2% -$127K 1.51% 18
2024
Q1 		$55.8M Hold
523,626
– – 1.45% 23
2023
Q4 		$52.1M Buy
523,626
+29,338
+6% +$2.47M 1.54% 20
2023
Q3 		$51.1M Buy
494,288
+150,000
+44% +$16.7M 1.78% 17
2023
Q2 		$41.8M Buy
344,288
+1,124
+0.3% +$150K 1.42% 23
2023
Q1 		$52.7M Buy
343,164
+197,928
+136% +$32.7M 2.19% 12
2022
Q4 		$26.1M Buy
145,236
+102,947
+243% +$16.8M 1.28% 22
2022
Q3 		$5M Buy
42,289
+37,546
+792% +$5.7M 0.25% 66
2022
Q2 		$678K Hold
4,743
– – 0.03% 111
2022
Q1 		$817K Sell
4,743
-1,454
-23% -$245K 0.03% 108
2021
Q4 		$1.57M Buy
6,197
+3,343
+117% +$977K 0.05% 94
2021
Q3 		$1.1M Sell
2,854
-181
-6% -$66.8K 0.04% 102
2021
Q2 		$713K Buy
3,035
+215
+8% +$38.4K 0.02% 116
2021
Q1 		$369K Buy
+2,820
New +$409K 0.01% 140

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s MRNA Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) reduced its Moderna (MRNA) stake by 92% in Q2 2026, selling an estimated $8M and leaving 13,947 shares worth $977K. The position accounts for 0.02% of the portfolio, ranked #142.

Bank Pictet & Cie (Europe) first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $62.1M in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 13,947 shares of Moderna worth $977K as of Q2 2026.
  • Bank Pictet & Cie (Europe) sold 154,659 Moderna shares in Q2 2026, an estimated $8M.
  • Moderna made up 0.02% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #142 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
  • Bank Pictet & Cie (Europe)'s Moderna position peaked at $62.1M in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.